Study of Leptin for the Treatment of Hypothalamic Amenorrhea

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to determine whether administration of an investigational medication called leptin (r-metHuLeptin) in replacement doses can improve bone health, reproductive function, hormone levels, immune function, and overall sense of well-being in women with hypothalamic (exercise-induced) amenorrhea (HA) who are being treated with oral contraceptive pills (OCPs), compared to placebo. Women with hypothalamic amenorrhea have low leptin levels. This study is based on the hypothesis that the relative leptin deficiency in women with hypothalamic (exercise-induced) amenorrhea may be the reason for the lack of menstrual cycles, hormone abnormalities, and bone loss associated with this condition.

Clinical Trial Description

Leptin is a hormone secreted by fat cells under normal conditions and acts in the brain to regulate energy usage and hormone levels. Women with HA who do not have regular periods have low leptin levels and may also have other hormone abnormalities as well as loss of bone density (osteopenia or osteoporosis). This study will evaluate how leptin (a fat cell hormone that normally circulates in the blood) affects bone density, menstrual periods, hormone levels, bone metabolism (how bone forms and turns over), immune function (how well the body can fight infection), metabolic rate (how many calories are used at rest), and overall sense of well-being and appetite in women with HA (i.e. no regular menstrual periods due to low levels of pituitary hormones that regulate estrogen production from the ovary). It will also investigate whether leptin replacement can be used as an adjunct to the current standard of care for HA patients, i.e. OCPs.

Part A is a Randomized, placebo-controlled 36-week study. Part B is an Optional open-label 52-week study. There will also be an optional Reward Sub-study, including healthy controls, designed to investigate leptin's relation to reward processing by collecting participants' brain and behavioral responses to images (e.g., pictures of food vs. non-food). Brain responses will be collected and will also be assessed via functional Magnetic Resonance Imaging (fMRI).

Comparison: Part A = leptin-treated group to placebo-treated group and Part B optional sub study = leptin-treated group to health controls ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Amenorrhea

Clinical Trial Details

NCT number	NCT00130117
Study type	Interventional
Source	Beth Israel Deaconess Medical Center
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	April 2010
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01927432` - Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
Completed	`NCT00196391` - A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea	Phase 2
Completed	`NCT00152282` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women	Phase 2
Recruiting	`NCT00456274` - Baselines in Reproductive Disorders	N/A
Terminated	`NCT00556400` - Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones	Phase 1/Phase 2
Completed	`NCT00429494` - GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients	Phase 2
Completed	`NCT04135729` - Mental Health in Fitness Instructors
Recruiting	`NCT03916978` - Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women	Phase 2/Phase 3
Completed	`NCT00243607` - Hydrotherapy Against Menopausal Symptoms in Breast Cancer Survivors	N/A
Completed	`NCT00001275` - Ovarian Follicle Function in Patients With Primary Ovarian Failure	N/A
Completed	`NCT04938622` - Bioenergetics of Exercise-Induced Menstrual Disturbances	N/A
Recruiting	`NCT06280807` - Observation of Environment and Reproductive-Endocrine Effects
Not yet recruiting	`NCT02393482` - Psychological Impact of Amenorrhea in Women With Endometriosis	Phase 4
Completed	`NCT01206153` - Metformin for Treatment Antipsychotic Induced Amenorrhea in Female Schizophrenic Patients	Phase 4
Recruiting	`NCT04424576` - Ovarian Morphology in Girls
Completed	`NCT02224976` - Effect of Intense Training on Ovarian Function and Bone Turnover	N/A
Active, not recruiting	`NCT01785719` - Evaluation of Ovarian Morphology and Function in Overweight Women During Weight Loss	N/A
Recruiting	`NCT00383656` - Pulsatile GnRH in Anovulatory Infertility	Phase 2
Terminated	`NCT00881608` - Study to Evaluate Menses Induction in Women Administered Proellex	Phase 1
Active, not recruiting	`NCT01103518` - Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.